Cardinal Point Capital Management ULC

Position in LLY — ELI LILLY & Co

CIK 1950841 TORONTO, A6

Position in LLY

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$1,209,025

+$343,522 QoQ

Shares Held

1,008

+7.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#2,957

of 4,605 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cardinal Point Capital Management ULC holds $32,470,942 across 7 Drug Manufacturers - General names. LLY ranks #5 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	72,763	$18,479,619
2	PFE	Pfizer Inc	332,062	$7,996,052
3	ABBV	AbbVie Inc.	8,437	$2,123,086
4	GILD	Gilead Sciences, Inc.	9,748	$1,231,562
5	LLY	ELI LILLY & Co This page	1,008	$1,209,025
6	MRK	Merck & Co., Inc.	6,290	$808,265
7	BMY	Bristol Myers Squibb Co	10,818	$623,333

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,209,025	1,008	+7.1%	Shares	Sole	2026-07-14
2026-03-31	$865,503	941	+43.4%	Shares	Sole	2026-04-20
2025-12-31	$704,990	656	+1.7%	Shares	Sole	2026-02-05
2025-09-30	$492,135	645	-9.3%	Shares	Sole	2025-11-06
2025-06-30	$554,245	711	+70.5%	Shares	Sole	2025-07-31
2025-03-31	$344,404	417	+3.0%	Shares	Sole	2025-05-08
2024-12-31	$312,660	405	+0.5%	Shares	Sole	2025-01-14
2024-09-30	$357,033	403	0.0%	Shares	Sole	2024-10-08
2024-06-30	$364,868	403	+1.0%	Shares	Sole	2024-07-12
2024-03-31	$310,406	399	+0.8%	Shares	Sole	2024-04-24
2023-12-31	$230,836	396	-24.7%	Shares	Sole	2024-01-12
2023-09-30	$282,530	526	—	Shares	Sole	2023-10-19
No filing history on record for this holder in this stock.